Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-jun N-terminal kinases

ACS Chemical Biology

Volumn 7, Issue 8, 2012, Pages 1356-1366

  Parizek, Petra ^a   Kummer, Lutz ^a   Rube, Peter ^b   Prinz, Anke ^b   Herberg, Friedrich W ^b   Plückthun, Andreas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF KASSEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANKYRIN; EPITOPE; MITOGEN ACTIVATED PROTEIN KINASE 9; STRESS ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ARTICLE; COMBINATORIAL LIBRARY; DRUG BINDING SITE; DRUG SELECTIVITY; PRIORITY JOURNAL; RIBOSOME;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANKYRIN REPEAT; BINDING SITES; BIOTINYLATION; CHROMATOGRAPHY; DRUG DESIGN; HEK293 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; MICE; PEPTIDES; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN ISOFORMS; PROTEIN KINASE INHIBITORS; SURFACE PLASMON RESONANCE;

EID: 84862014201     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb3001167     Document Type: Article

References (48)

1. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain Genes Dev. 7, 2135-2148
2. Boulton, T. G. and Cobb, M. H. (1991) Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies Cell Regul. 2, 357-371
3. Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells Science 265, 808-811
4. Zhou, G., Bao, Z. Q., and Dixon, J. E. (1995) Components of a new human protein kinase signal transduction pathway J. Biol. Chem. 270, 12665-12669
5. Kyriakis, J. M. and Avruch, J. (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol. Rev. 81, 807-869
6. Chen, Z., Gibson, T. B., Robinson, F., Silvestro, L., Pearson, G., Xu, B., Wright, A., Vanderbilt, C., and Cobb, M. H. (2001) MAP kinases Chem. Rev. 101, 2449-2476
7. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Derijard, B., and Davis, R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors EMBO J. 15, 2760-2770
8. Bogoyevitch, M. A. (2006) The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): differences revealed by gene targeting BioEssays 28, 923-934
9. Bogoyevitch, M. A. and Arthur, P. G. (2008) Inhibitors of c-Jun N-terminal kinases: JuNK no more? Biochim. Biophys. Acta 1784, 76-93
10. Bogoyevitch, M. A., Ngoei, K. R., Zhao, T. T., Yeap, Y. Y., and Ng, D. C. (2010) c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges Biochim. Biophys. Acta 1804, 463-475
11. Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S. S., Manning, A. M., and Anderson, D. W. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Proc. Natl. Acad. Sci. U.S.A. 98, 13681-13686
12. Bogoyevitch, M. A. (2005) Therapeutic promise of JNK ATP-noncompetitive inhibitors Trends Mol. Med. 11, 232-239
13. Ngoei, K. R., Catimel, B., Church, N., Lio, D. S., Dogovski, C., Perugini, M. A., Watt, P. M., Cheng, H. C., Ng, D. C., and Bogoyevitch, M. A. (2011) Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide Biochem. J. 434, 399-413
14. Wörn, A. and Plückthun, A. (2001) Stability engineering of antibody single-chain Fv fragments J. Mol. Biol. 305, 989-1010
15. Philibert, P., Stoessel, A., Wang, W., Sibler, A. P., Bec, N., Larroque, C., Saven, J. G., Courtete, J., Weiss, E., and Martineau, P. (2007) A focused antibody library for selecting scFvs expressed at high levels in the cytoplasm BMC Biotechnol. 7, 81
16. Perez-Martinez, D., Tanaka, T., and Rabbitts, T. H. (2010) Intracellular antibodies and cancer: new technologies offer therapeutic opportunities BioEssays 32, 589-598
17. Harmsen, M. M. and De Haard, H. J. (2007) Properties, production, and applications of camelid single-domain antibody fragments Appl. Microbiol. Biotechnol. 77, 13-22
18. Gilbreth, R. N., Truong, K., Madu, I., Koide, A., Wojcik, J. B., Li, N. S., Piccirilli, J. A., Chen, Y., and Koide, S. (2011) Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design Proc. Natl. Acad. Sci. U.S.A. 108, 7751-7756
19. Wojcik, J., Hantschel, O., Grebien, F., Kaupe, I., Bennett, K. L., Barkinge, J., Jones, R. B., Koide, A., Superti-Furga, G., and Koide, S. (2010) A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain Nat. Struct. Mol. Biol. 17, 519-527
20. Binz, H. K., Stumpp, M. T., Forrer, P., Amstutz, P., and Plückthun, A. (2003) Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins J. Mol. Biol. 332, 489-503
21. Boersma, Y. L. and Plückthun, A. (2011) DARPins and other repeat protein scaffolds: advances in engineering and applications Curr. Opin. Biotechnol. 22, 849-857
22. Bork, P. (1993) Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins 17, 363-374
23. Canepa, E. T., Scassa, M. E., Ceruti, J. M., Marazita, M. C., Carcagno, A. L., Sirkin, P. F., and Ogara, M. F. (2007) INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions IUBMB Life 59, 419-426
24. Forrer, P., Stumpp, M. T., Binz, H. K., and Plückthun, A. (2003) A novel strategy to design binding molecules harnessing the modular nature of repeat proteins FEBS Lett. 539, 2-6
25. Hanes, J. and Plückthun, A. (1997) In vitro selection and evolution of functional proteins by using ribosome display Proc. Natl. Acad. Sci. U.S.A. 94, 4937-4942
26. Steiner, D., Forrer, P., Stumpp, M. T., and Plückthun, A. (2006) Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display Nat. Biotechnol. 24, 823-831
27. Binz, H. K., Amstutz, P., Kohl, A., Stumpp, M. T., Briand, C., Forrer, P., Grütter, M. G., and Plückthun, A. (2004) High-affinity binders selected from designed ankyrin repeat protein libraries Nat. Biotechnol. 22, 575-582
28. Zahnd, C., Pecorari, F., Straumann, N., Wyler, E., and Plückthun, A. (2006) Selection and characterization of Her2 binding-designed ankyrin repeat proteins J. Biol. Chem. 281, 35167-35175
29. Steiner, D., Forrer, P., and Plückthun, A. (2008) Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display J. Mol. Biol. 382, 1211-1227
30. Stefan, N., Martin-Killias, P., Wyss-Stoeckle, S., Honegger, A., Zangemeister-Wittke, U., and Plückthun, A. (2011) DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency J. Mol. Biol. 413, 826-843
31. Amstutz, P., Binz, H. K., Parizek, P., Stumpp, M. T., Kohl, A., Grütter, M. G., Forrer, P., and Plückthun, A. (2005) Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteins J. Biol. Chem. 280, 24715-24722
32. Kohl, A., Amstutz, P., Parizek, P., Binz, H. K., Briand, C., Capitani, G., Forrer, P., Plückthun, A., and Grütter, M. G. (2005) Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat protein Structure 13, 1131-1141
33. Wyler, E., Kaminska, M., Coic, Y. M., Baleux, F., Veron, M., and Agou, F. (2007) Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEM Protein Sci. 16, 2013-2022
34. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., and Davis, R. J. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288, 870-874
35. Finch, A., Davis, W., Carter, W. G., and Saklatvala, J. (2001) Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7 Biochem. J. 353, 275-281
36. Altan, Z. M. and Fenteany, G. (2004) c-Jun N-terminal kinase regulates lamellipodial protrusion and cell sheet migration during epithelial wound closure by a gene expression-independent mechanism Biochem. Biophys. Res. Commun. 322, 56-67
37. Dreskin, S. C., Thomas, G. W., Dale, S. N., and Heasley, L. E. (2001) Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells J. Immunol. 166, 5646-5653
38. Forrer, P. and Jaussi, R. (1998) High-level expression of soluble heterologous proteins in the cytoplasm of Escherichia coli by fusion to the bacteriophage lambda head protein D Gene 224, 45-52
39. Forrer, P., Tamaskovic, R., and Jaussi, R. (1998) Enzyme-linked immunosorbent assay for measurement of JNK, ERK, and p38 kinase activities Biol. Chem. 379, 1101-1111
40. Kummer, L., Parizek, P., Rube, P., Millgramm, B., Prinz, A., Mittl, P. R. E., Kaufholz, M., Zimmermann, B., Herberg, F. W., and Plückthun, A. Phosphorylation-specific ERK kinase-binders from designed ankyrin repeat protein libraries. Proc. Natl. Acad. Sci. U.S.A. 2012, in press.
41. Amstutz, P., Koch, H., Binz, H. K., Deuber, S. A., and Plückthun, A. (2006) Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries Protein Eng. Des. Sel. 19, 219-229
42. Prinz, A., Diskar, M., Erlbruch, A., and Herberg, F. W. (2006)) Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET) Cell. Signalling 18, 1616-1625
43. Cano, E., Doza, Y. N., Ben-Levy, R., Cohen, P., and Mahadevan, L. C. (1996) Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2 Oncogene 12, 805-812
44. Amalfitano, A. and Parks, R. J. (2002) Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy Curr. Gene Ther. 2, 111-133
45. Xia, X. G., Harding, T., Weller, M., Bieneman, A., Uney, J. B., and Schulz, J. B. (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease Proc. Natl. Acad. Sci. U.S.A. 98, 10433-10438
46. Dreier, B., Mikheeva, G., Belousova, N., Parizek, P., Boczek, E., Jelesarov, I., Forrer, P., Plückthun, A., and Krasnykh, V. (2011) Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting J. Mol. Biol. 405, 410-426
47. Huber, T., Steiner, D., Röthlisberger, D., and Plückthun, A. (2007) In vitro selection and characterization of DARPins and Fab fragments for the co-crystallization of membrane proteins: The Na(+)-citrate symporter CitS as an example J. Struct. Biol. 159, 206-221
48. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994) JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell 76, 1025-1037